Logo

Takeda Collaborates with Evotec on RNA Targeting Drug Development

Share this

Takeda Collaborates with Evotec on RNA Targeting Drug Development

Shots:

  • Evotec to receive research funding and will be eligible for $160M/program as discovery- pre/ clinical- a commercial milestone along with royalties on sales of product emerges from the collaboration
  • The collaboration will utilize Evotec’s RNA targeting platform to identify RNA sequences to target with small-molecule ligands aligned that can be developed into the first-in-class therapeutics
  • The companies will jointly identify & develop small molecules targeting a range of RNA targets aligned with Takeda’s research and development areas

 ­ Ref: Evotec | Image: Wikipedia

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions